Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited Settings
Clinical Infectious Diseases2010Vol. 51(4), pp. 448–455
Citations Over TimeTop 1% of 2010 papers
David B. Meya, Yukari C. Manabe, Barbara Castelnuovo, Bethany Cook, Ali Elbireer, Andrew Kambugu, Moses R. Kamya, Paul R. Bohjanen, David R. Boulware
Abstract
Integrating CRAG screening into HIV care, specifically targeting people with severe immunosuppression (CD4(+) cell count < or = 100 cells/microL) should be implemented in treatment programs in resource-limited settings. ART alone is insufficient treatment for CRAG-positive persons.
Related Papers
- → Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients(1998)45 cited
- → Efficacy of CS-758, a Novel Triazole, against Experimental Fluconazole-Resistant Oropharyngeal Candidiasis in Mice(2003)9 cited
- → Subclinical Hypothyroidism(2010)3 cited
- → Overt and Subclinical Hyperthyroidism Are Associated with Increased Mortality Whereas Subclinical Hypothyroidism Is Associated with Decreased Mortality(2014)
- STUDY ON THE RELATIONSHIP BETWEEN SUBCLINICAL EPILEPTIFORM DISCHARGE AND TCI(2002)